Introduction of everolimus is associated with a reduction in the dosage of calcineurine-inhibitors in patients with a pulmonary graft who suffer from a notable chronic renal insuffisance.
Latest Information Update: 15 Mar 2022
At a glance
- Drugs Everolimus (Primary)
- Indications Renal failure
- Focus Therapeutic Use
Most Recent Events
- 15 Mar 2022 New trial record